Top news of the week: 16.08.2022.
Pam Belluck and Stephanie M. Lee share 2022 Victor Cohn Prize
Pam Belluck Pam Belluck began uncovering medical stories as a national bureau chief at the Times, initiating important enterprise stories on Alzheimer’s disease and mental …
Early-stage VC valuations see their first decline in 10 quarters
New data shows weakness across the board, from seed stage to unicorns.
Gemini’s fall gives Disc a way around biotech’s IPO slump
The biotech’s failed attempt to develop an eye disease drug has ended in a reverse merger that gives startup Disc Medicine a fast path to the public markets.
Amid market turbulence, a Flagship startup pushes off an IPO with a new fundraise
Senda Biosciences decided to raise a $123 million Series C round rather than test public markets with an initial offering, its top executive said.
Cathy Tie Builds Locke Bio To Be ‘Shopify’ For Health industry
Founded in 2019 by then 23-year-old entrepreneur, Thiel Fellow and Forbes 30 under 30 member Kathy Tie, B2B technology company Locke Bio is building the "Shopify" for the health industry. ...
‘Treg’ cell therapy: bringing CAR-T to autoimmune disease
At least seven companies, including five richly funded startups, are developing cell-based treatments for inflammatory conditions, making it one of biotech’s most competitive fields.
Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development
Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35
Merck pays startup Orna $150M as ‘circular RNA’ attracts industry interest
The pharmaceutical company has formed an alliance with Orna and invested $100 million in its Series B round, hoping the young biotech’s approach could lead to multiple new vaccines and ...